KEY MEMBERS
NeoImmuneTech, Inc. (NIT) is led by seasoned executives relentlessly pursuing the development of novel drug in immuno-oncology.
Se Hwan Yang, Ph.D. - President / Chief Executive Officer
Dr. Se Hwan Yang founded NeoImmuneTech in January 2014. Dr. Yang has created several intellectual-property protected inventions, including the hyFc® platform technology and drug candidate. Prior to his position at NIT, Dr. Yang was Genexine’s Head of Research Institute and Business division from 2007 to 2014 and has served as a BOD member of Genexine. He received his Ph.D. from Pohang University of Science and Technology and has over 20 years of experiences of research, product development and business in life sciences, including molecular biology, immunology and protein engineering.
Dr. Se Hwan Yang founded NeoImmuneTech in January 2014. Dr. Yang has created several intellectual-property protected inventions, including the hyFc® platform technology and drug candidate. Prior to his position at NIT, Dr. Yang was Genexine’s Head of Research Institute and Business division from 2007 to 2014 and has served as a BOD member of Genexine. He received his Ph.D. from Pohang University of Science and Technology and has over 20 years of experiences of research, product development and business in life sciences, including molecular biology, immunology and protein engineering.
KEY MEMBERS
Clinical Division
Byung Ha Lee
Ph.D.
Chief Scientific Officer
/ Head of Clinical Division
Hye Jeong
M.D.
Medical Director of Drug
Safety and Pharmacovigilance
Sara Ferrando Martinez
Ph.D.
Head of Clinical Sciences
Mary E. Muench-Holum
Head of Clinical Operations
Quality Assurance Division
Jiyoung Joo
Chief Quality Officer
/ Head of QA Division
Hee Yong Jeong
Director
of CMC QA
Richard Sloma
Senior Director of
Clinical QA
CMC Division
Eun Jeong Bae
Head of CMC Division
Regulatory Affairs Division
Jin Hee Kang
Chief Regulatory Officer
/ Head of RA Division
Alicia Staz
RA Director
Research Institute
Donghoon Choi
Ph.D.
Chief Technology Officer
/ Head of Research Institute
Business Development
Daniel Rho
Director of Business
Development
Global Strategy Division
Jin Hee Kang
Head of GS Division
Hyun Jee Kim
Director of Strategy &
Planning
Finance Division
Tae Woo Kim
CPA
Chief Financial Officer
/ Head of Finance Division
Management Division
Gene Namgoong
Chief Operating Officer
/ Head of Management Division
Dana Wyche
IT Director
Soon Phil Lee
Head of Management Department (KR)